Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
After the Democratic Midterm Sweep: 4 Dividend Stocks Built for Gridlock
Benjamin Graham Had a 20-Year Rule for Retirement Income. It Just Won the AI Sell-Off
Is JNJ Overvalued? DCF Says Worth $134
Johnson & Johnson $JNJ Stock: Fulcrum Asset Management LLP Grows Position
ETFs Are Net Sellers of Johnson & Johnson (JNJ) on Nov. 5
23,106 Shares in Johnson & Johnson $JNJ Purchased by Elite Wealth Management Inc.
Johnson & Johnson $JNJ Holdings Cut by Carnegie Lake Advisors LLC
Johnson & Johnson $JNJ Holdings Boosted by Candriam S.C.A.
Johnson & Johnson Reports Early Clinical Data For Pasritamig, JNJ-9401 In Advanced Prostate Cancer
Johnson & Johnson $JNJ Stock Bought by Allspring Global Investments Holdings LLC
Johnson & Johnson $JNJ Shares Newly Purchased by M Holdings Securities Inc. - Daily Political
Johnson & Johnson Shares Patient Experience Data from Phase 2 DA
Johnson & Johnson (JNJ): Limited Analyst Upside, but Management Sees a Clearer Path to Growth
Johnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancer | Morningstar
3 Dividend Stocks Worth Researching This Weekend
Johnson & Johnson $JNJ Stock Sold by Palisade Asset Management LLC
What Could Johnson & Johnson (JNJ) ICOTYDE Trial Results Change For Its Growth? - Simply Wall St News
Johnson & Johnson $JNJ Stock: Pictet Asset Management Holding SA Raises Stake
Best Pharmaceutical Stocks To Watch Today - November 8th - Daily Political
Johnson & Johnson $JNJ Stock: Ethic Inc. Grows Stake - Markets Daily
Formidable Asset Management LLC Sells 3,813 Shares of Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Stock: 180 Wealth Advisors LLC Increases Stake
Johnson & Johnson $JNJ Holdings Reduced by Kornitzer Capital Management Inc. KS - Daily Political
Johnson & Johnson $JNJ Stock Position Boosted by Kestra Advisory Services LLC
Promising Pharmaceutical Stocks To Research - November 7th - Stock Observer
Johnson & Johnson announces ICOTYDE® (icotrokinra) delivers significant improvement in psoriatic arthritis disease activity among biologic-naive patients with once-daily targeted oral peptide | Morningstar
Analyzing Johnson & Johnson (JNJ) and The Competition - Stock Observer
Johnson & Johnson $JNJ Stake Boosted by Asset One Wealth Management LLC - Markets Daily
Johnson & Johnson (JNJ) Stock May Be 41% Undervalued Following FDA Approval - Simply Wall St News
Johnson & Johnson $JNJ Shares Sold by Alps Advisors Inc.
26,805 Johnson & Johnson $JNJ Shares Purchased by Kestra Advisory Services LLC - Daily Political
Johnson & Johnson $JNJ Stock Sold by ACR Alpine Capital Research LLC
Johnson & Johnson (NYSE:JNJ) Stock Jumps 1.4% - Should You Buy?
Johnson & Johnson (JNJ) Stock: Rises to $273 as FDA Approves RYBREVANT FASPRO for Head and Neck Cancer
Johnson & Johnson (NYSE:JNJ) Stock Jumps 1.4% - Here's What Happened - Stock Observer
J&J's RYBREVANT FASPRO Approved By FDA For Advanced Head And Neck Cancer; Stock Down
4 Dividend Raisers With Balance Sheets Strong Enough to Keep Raising Through Any Downturn
5 High-Yield Dividend Stocks That Could Hold Up When the Market Falls
2,131 Johnson & Johnson $JNJ Shares Sold by Brady Family Wealth LLC
Johnson & Johnson $JNJ Holdings Cut by Inscription Capital LLC
Johnson & Johnson $JNJ Shares Sold by Commonwealth Equity Services LLC
J&J's Rybrevant Faspro Wins FDA Accelerated Approval For Advanced Head And Neck Cancer
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Johnson & Johnson - JNJ | Morningstar
Inscription Capital LLC Sells 4,140 Shares of Johnson & Johnson $JNJ - Daily Political
Johnson & Johnson (NYSE:JNJ) Stock Falls 1.4% - Here's Why
Johnson & Johnson (NYSE:JNJ) Stock Falls 1.6% - Here's Why - Stock Observer
4 Dividend Kings That Could Pay You for the Rest of Your Retirement
Genmab nine-month revenue rises 22% as late-stage pipeline delivers
3 Dependable Dividend Stocks for a $250,000 Passive Income Strategy
Rate Hikes Could Be Coming: History Likes These 4 Dividend Stocks
Johnson & Johnson $JNJ Shares Acquired by Rakuten Investment Management Inc.
Healthcare Stocks To Keep An Eye On - November 5th - Daily Political
Johnson & Johnson $JNJ Stock Holdings Lifted by Provenance Wealth Advisors LLC
Johnson & Johnson $JNJ Stock: TrinityBridge Ltd Boosts Position - Markets Daily
Johnson & Johnson $JNJ Stock: AIA Group Ltd Lowers Holdings
148,455 Shares in Johnson & Johnson $JNJ Acquired by Associated Banc Corp
87,682 Johnson & Johnson $JNJ Shares Purchased by TrinityBridge Ltd - Stock Observer
Johnson & Johnson $JNJ Stock Position Cut by Parr Mcknight Wealth Management Group LLC - Daily Political
Johnson & Johnson (NYSE:JNJ) Stock Jumps 3.9% - Should You Buy?
4 Biotech Stocks Likely to Outpace Q3 Earnings Estimates
First Nebraska Trust Co Acquires New Shares in Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Stock Acquired by VCI Wealth Management LLC
Johnson & Johnson $JNJ Stock Sold by Focused Investors LLC
Johnson & Johnson $JNJ Stock: Coerente Capital Management Decreases Stake
Johnson & Johnson $JNJ Stock Bought by BOCHK Asset Management Ltd
Johnson & Johnson $JNJ Position Raised by Aware Super Pty Ltd as trustee of Aware Super
Could Johnson & Johnson (JNJ) Impella Data Reshape High Risk Heart Care? - Simply Wall St News
4,570 Shares of Johnson & Johnson $JNJ Purchased by TSG Advice Partners LLC - Daily Political
Johnson & Johnson $JNJ Stock: One Way Holdings LLC Raises Holdings - Daily Political
First Nebraska Trust Co Makes New $17.63 Million Investment in Johnson & Johnson $JNJ - Daily Political
Pomerantz Investigates Investor Claims at Five Firms
Johnson & Johnson (NYSE:JNJ) Shares Down 1.6% - Time to Sell?
AbbVie Hit a New High After Earnings. There's More Upside Left. - 24/7 Wall St.
Johnson & Johnson $JNJ Shares Sold by ProShare Advisors LLC - Markets Daily
Johnson & Johnson $JNJ Stock Sold by Welch Group LLC - Markets Daily
Johnson & Johnson $JNJ Stock: Sumitomo Mitsui Trust Group Inc. Cuts Stake - Zolmax
Promising Healthcare Stocks Worth Watching - November 3rd - Daily Political
Genmab cancer drug wins fuel shift to owning more medicines
Johnson & Johnson $JNJ Stock Purchased by Hollow Brook Wealth Management LLC
Johnson & Johnson $JNJ Stake Boosted by Investment Partners LTD.
Johnson & Johnson $JNJ Stock: ProShare Advisors LLC Reduces Stake - Stock Observer
Johnson & Johnson $JNJ Position Boosted by Bank Julius Baer & Co. Ltd Zurich
Johnson & Johnson $JNJ Holdings Reduced by Welch Group LLC - Stock Observer
Trek Financial LLC Sells 25,622 Shares of Johnson & Johnson $JNJ - Stock Observer
Johnson & Johnson (NYSE:JNJ) Stock Sale Reported by Rep. Thomas H. Kean, Jr. - Daily Political
Johnson & Johnson $JNJ Position Trimmed by Sumitomo Mitsui Trust Group Inc. - Daily Political
Securitize expands tokenized US stock offering to 25 equities
Johnson & Johnson (JNJ) As Impella Data Fuels The Story, Is The Stock Fully Valued?
2 Safe S&P 500 Healthcare Dividend Stocks Boomers Can Buy and Hold Forever - AOL
3 Best Dividend Stocks for a $100,000 Passive Income Strategy
Summit Global Investments Purchases 6,030 Shares of Johnson & Johnson $JNJ
Johnson & Johnson Reports Lower Mortality Rates in Impella-Supported High-Risk Coronary Procedures
JnJ News
Micron Stock Price Forecast 2026–2030: Can AI Memory Demand Reverse a 26% Week-to-Date Sell-Off?
Arm Holdings Stock Forecast 2026–2030: Can Data-Center Royalty Growth Drive a Recovery?
Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?
Latest news
Show more
Gold Price Today: XAU/USD Rises Above $4,100 Ahead of US Inflation Data
Nvidia Board Opens Huang Investigation as AI Financing Risks Draw Scrutiny
Solana Price Near $86 as Support Break Raises Risk of Further Losses
Gold Price Forecast This Week: Can XAU/USD Hold $4,000 Before US CPI?
US CPI Preview: Will October Inflation Lock In a December Fed Rate Hike?
Nasdaq Falls 5.52% as AI Selloff Drives S&P 500’s Worst Day Since April 2025
